Effects of vorapaxar on clot characteristics, coagulation, inflammation, and platelet and endothelial function in patients treated with mono‐ and dual‐antiplatelet therapy-Reference-Cited by-同舟云学术

Effects of vorapaxar on clot characteristics, coagulation, inflammation, and platelet and endothelial function in patients treated with mono‐ and dual‐antiplatelet therapy

Published:2019-09-17 Issue:1 Volume:18 Page:23-35
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Bliden Kevin¹,Chaudhary Rahul²,Kuliopulos Athan³,Tran Henry¹,Taheri Hamid¹,Tehrani Behnam¹,Rosenblatt Arnold¹,Navarese Eliano¹,Tantry Udaya S.⁴,Gurbel Paul A.¹

Affiliation:

1. Inova Center for Thrombosis Research and Drug Development Inova Heart and Vascular Institute Fairfax VA USA

2. Division of Hospital Internal Medicine Mayo Clinic Rochester MN USA

3. Center for Hemostasis and Thrombosis Research Tufts Medical Center Boston MA USA

4. Sinai Center for Thrombosis Research Sinai Hospital of Baltimore Baltimore MD USA

Funder

Merck

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.14616

Reference24 articles.

1. Combination Antithrombotic Therapies

2. Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding

3. Combination oral antithrombotic therapy for the treatment of myocardial infarction: recent developments

4. Residual platelet activation through protease-activated receptors (PAR)-1 and ‐4 in patients on P2Y12 inhibitors

5. Vorapaxar in the secondary prevention of atherothrombosis

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protease-activated receptors and glycoprotein VI cooperatively drive the platelet component in thromboelastography;Journal of Thrombosis and Haemostasis;2023-08

2. Suppression of Heart Failure With PAR1 Pepducin Technology in a Pressure Overload Model in Mice;Circulation: Heart Failure;2023-07-21

3. Species Differences in Platelet Protease-Activated Receptors;International Journal of Molecular Sciences;2023-05-05

4. Efficacy of medical treatment and balloon angioplasty for severe intracranial atherosclerosis: a high-resolution MR vessel wall imaging;European Radiology;2022-11-23

5. Clinical pharmacology of antiplatelet drugs;Expert Review of Clinical Pharmacology;2022-09-11